Krystal Biotech Inc

NASDAQ:KRYS   3:59:53 PM EDT
70.69
+1.01 (+1.45%)
Earnings Announcements

Krystal Biotech Reports Third Quarter 2021 Financial Results

Published: 11/08/2021 12:35 GMT
Krystal Biotech Inc (KRYS) - Krystal Biotech Reports Third Quarter 2021 Financial Results and Provides Update on Operational Progress.
Qtrly Loss per Share $0.70.
Q3 Earnings per Share View $-0.74 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.72

Next Quarter Revenue Guidance is expected to be $0.03 Million
Next Quarter EPS Guidance is expected to be -$0.79

More details on our Analysts Page.